We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
48 hedge funds and large institutions have $77.2M invested in Regulus Therapeutics in 2017 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
244% more capital invested
Capital invested by funds: $22.4M → $77.2M (+$54.8M)
38% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 13
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
4% more funds holding
Funds holding: 46 → 48 (+2)
0.14% more ownership
Funds ownership: 0.36% → 0.5% (+0.14%)
Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
18
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$11.5M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$10.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.96M |
| 4 |
BC
Broadfin Capital
New York
|
+$4.5M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
+$2.3M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$363K |
| 2 |
ARTA
A.R.T. Advisors
New York
|
-$246K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$216K |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$164K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$144K |
